Skip to main content
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 2016 Sep;98(7):446–449. doi: 10.1308/rcsann.2016.0209

Musculoskeletal infections associated with Citrobacter koseri

TA Kwaees 1,, Z Hakim 1, C Weerasinghe 1, P Dunkow 1
PMCID: PMC5210019  PMID: 27412805

Abstract

Introduction

Citrobacter koseri is a well known cause of central nervous system infections in the paediatric setting. Musculoskeletal infections caused by C koseri are rare, with only 14 previously reported cases. We present the first recorded case of C koseri induced septic arthritis of the knee along with a review of the literature.

Methods

A search of the PubMed, Embase® and Google Scholar™ databases was undertaken. Only complete or near complete cases were reviewed.

Findings

Fourteen musculoskeletal infections were identified. Of these, five were associated with an operative procedure and five involved a septic joint. Surgical treatment was required in the majority of cases and cure was achieved in all cases following prolonged antibiotic use.

Conclusions

C koseri associated musculoskeletal infections may complicate primary orthopaedic procedures. The organism can present aggressively and can be difficult to identify microbiologically. It is sensitive to newer generation beta-lactams, cephalosporin-based antibiotics and timely surgery.

Keywords: Citrobacter koseri, Septic arthritis, Arthroscopy, Periprosthetic infection


Infection is the most common complication following knee arthroscopy, occurring in approximately 0.85% of all procedures.1Staphylococcus spp are the predominant cause, especially meticillin resistant Staphylococcus aureus (MRSA).2 Gram-negative organisms are cultured in up to 20% of patients with bacterial septic arthritis, and are seen primarily in children, the elderly, immunosuppressed individuals and intravenous drug users.2 Gonococcal organisms are now a less common cause of septic arthritis in Europe and North America.3 Rarer organisms have been known to cause septic arthritis but only five previous cases have involved Citrobacter koseri.

Citrobacter spp are commonly found in the environment and the intestinal tracts of mammals.3Citrobacter freundii and C koseri are the leading cause of human disease, and occur typically in the hospital setting.4C koseri is a known cause of neonatal meningitis and brain abscess.5 However, infections of the musculoskeletal system are exceedingly rare. In addition to a review of musculoskeletal infections caused by C koseri, we present the first case of C koseri induced septic arthritis of the knee.

Case history

A 72-year-old avid golfer presented to the emergency department complaining of right knee pain. He was referred by his general practitioner with a progressively worsening three-week history of knee inflammation following arthroscopy. On examination, his knee was grossly swollen with a marked effusion, warm and painful on palpation. The knee was held at 30° of flexion with under 10° of movement in either direction. He had been unable to bear weight for the preceding 7–10 days and a pitting oedema of the leg had begun to develop.

The patient’s medical history was relatively unremarkable, with a 30-year history of well controlled gout and a recent diagnosis of hypercholesterolaemia, for which he took allopurinol and simvastatin. He had undergone an arthroscopic meniscectomy three weeks prior to his presentation, which was completed successfully. His recovery had been unremarkable up until one week following the procedure, when his knee gradually showed signs of infection, for which his general practitioner prescribed oral flucloxacillin 500mg four times daily and co-codamol (8 days before his presentation to the emergency department) with minimal effect. Blood tests taken on admission revealed elevated C-reactive protein of 218mg/l but no other significant abnormalities on either haematology or biochemistry. Knee radiography on admission demonstrated only mild osteoarthritic changes. Knee aspiration was performed and the sample sent for Gram staining, which yielded negative results.

Less than 24 hours following his emergency admission, the patient underwent an arthroscopic washout of his right knee with immediate relief of symptoms. Intraoperative samples were sent for culture, and he was started on non-steroidal anti-inflammatory drugs and intravenous antibiotics (flucloxacillin 4g daily). Passive motion exercises to the right knee were continued. Two weeks following surgery, the knee was again inflamed and the patient was unable to bear weight. As a consequence, the flucloxacillin dose was increased to 8g daily and a second arthroscopic knee washout was performed. It was during this period that extended culture results from the initial knee aspiration and arthroscopy indicated septic arthritis due to C koseri. The patient was subsequently started on four weeks of intravenous ertapenem with a subsequent rapid improvement and full recovery.

Methods

A search of the PubMed, Embase® and Google Scholar™ databases was undertaken (from the year of their establishment to October 2015) using combinations of the following search terms: ‘Citrobacter’, ‘diversus’, ‘koseri’, ‘septic arthritis’, ‘osteomyelitis’, ‘bone’, ‘joint’ and ‘infection’. Relevant results included both singular cases presented alone and sufficiently described cases reported as part of a larger cohort. The full text and reference lists of articles were reviewed for any additional publications that could have been missed during the database search.

Findings

Septic arthritis is an infection of a joint caused most commonly by bacteria, especially Neisseria gonorrhoeae, S aureus and the Streptococcus genus.6 N gonorrhoeae is responsible for the majority of cases in young, sexually active patients while the majority of the remaining cases occur in the immunocompromised and those with an artificial joint.69

Diagnosis is clinical but aided by routine laboratory tests and joint aspiration for Gram staining and culture. Radiology for assessment of joint and bony integrity may occasionally be required but is of limited value.69 Confirming the diagnosis of periprosthetic infections is more challenging given the clinical implications and chronicity of the disease but recent advances with the use of synovial fluid biomarkers may improve the process.10 Treatment consists of urgent intravenous antibiotics, and rapid joint drainage and washout.7,8 In cases where septic arthritis develops following joint arthroplasty, the entire prosthesis should be removed and time allowed for the infection to settle prior to revision surgery.79

C koseri is a non-sporulating, aerobic, Gram-negative bacilli of the Enterobacteriaceae family. Belonging to this genus are C freundii and C koseri, which account for the majority of human illness.4,11 They are frequently found in soil, water and as part of the normal gastrointestinal and genitourinary flora of many animal species (including our own).4,5,11,12 Over 70% of Citrobacter infections are nosocomial and they are frequently associated with invasive procedures.4 As a group, they most commonly infect the urinary and digestive tracts in immunocompromised individuals but are rarely involved in infections of the musculoskeletal (MSK) system.35,11,13,14C koseri is a well known cause of severe central nervous system infections in neonates, where it is fatal in 30% and permanently debilitating in as many as 80% of those afflicted.1518

MSK infections secondary to C koseri are exceedingly rare, with only 14 previously reported cases identified since the 1980s (Table 1).12,15,16,1928 Only five of these involved septic arthritis,16,19,20,26,27 with two of these pertaining to artificial joints.26,27 The first two reported cases with septic arthritis occurred in middle aged men with a history of alcoholism.19,20 In both cases, treatment required drainage and prolonged antibiotics for 6–8 weeks.

Table 1.

Summary of Citrobacter koseri musculoskeletal infections. All cases were cured.

Reference Age in years Site Type of infection Co-morbidities Antibiotics (duration inweeks)* Surgery Cultures**
Lipsky, 198012 59 Foot Osteomyelitis DM, PVD Cefazolin (NA) Amputation C koseri
Lipsky, 198012 54 Foot Osteomyelitis DM, BPD Erythromycin + cefazolin + meticillin (NA) Amputation S aureus, S agalactiae, C koseri
Jansen, 198115 Neonate Proximal tibia Osteomyelitis Intrapartum asphyxia Cefamandole + gentamicin (6) Nil C koseri
Holt, 198119 47 Sternoclavicular joint Septic arthritis, osteomyelitis Hypoprothrombinaemia, alcoholism Moxalactam (6), followed by cefradine (8) Spontaneous drainage C koseri
Fuxench-Chiesa, 198320 45 Sternoclavicular joint Septic arthritis, osteomyelitis Alcoholism Moxalactam (6) Open drainage C koseri
Boberg, 198421 45 Foot (surgical site infection) Osteomyelitis HTN, hypothyroidism Cefotaxime (2), followed by cefalexin (2) Resection of 4th metatarsal head C koseri
Simons, 198522 70 Foot Osteomyelitis NA Aztreonam (4) Debridement C koseri, S aureus
Müllner, 199223 74 Lumbar vertebraea Osteomyelitis Pneumonia, OA, AF, cholelithiasis, GORD, smoker Ofloxacin (3), followed by ciprofloxacin (2) Debridement C koseri, K pneumoniae, S epidermidis
Sotto, 199424 72 Cervical vertebrae and disc Discitis, osteomyelitis Angina, HTN, recent prostatectomy Amikacin (3) + imipenem (11) Percutaneous drainage C koseri
Hayani, 199716 Neonate Glenohumeral joint Septic arthritis, osteomyelitis Proximal humerus fracture Gentamicin + ceftriaxone (3) Debridement C koseri
Canario, 200425 42 Vertebrae, psoas muscle Osteomyelitis, abscess TB, infected metalwork Levofloxacin (>4)b Laminectomy, drainage and metal removal C koseri
Maynou, 200626 54 Shoulder prosthesisc Septic arthritis NA NA (12) Prosthesis resection C koseri
Kaufman, 201127 53 Hip prosthesis Septic arthritis DM, gout, obesity, HTN Ertapenem (6) Debridement, prosthesis exchange C koseri
Yagci, 201128 68 Foot Osteomyelitis DM, PVD Piperacillin/tazobactam (3), followed by moxifloxacin (3) Debridement E coli, C koseri
Present case 72 Knee Septic arthritis Gout, hypercholesterolaemia Ertapenem (4) Arthroscopic washout C koseri

AF = atrial fibrillation; BPD = bronchopulmonary dysplasia; DM = diabetes mellitus; GORD = gastro-oesophageal reflux; HTN = hypertension; NA = not available; OA = osteoarthritis; PVD = peripheral vascular disease; TB = tuberculosis

*The duration of antibiotic treatment has been rounded to the nearest week.

**Cases reported as C diversus have been listed as C koseri.

aCase consisted of two admissions; bPatient treated with 4 weeks of oral levofloxacin in addition to an undefined period of parenteral treatment; cLimited information available as case reported within a wider series

In the third case, a three-week-old neonate developed a septic glenohumeral joint with associated osteomyelitis two weeks after sustaining a growth plate fracture of the ipsilateral humerus.16 The infant was managed with urgent surgical debridement and targeted antibiotics following C koseri positive culture results. Despite over 20 days of antibiotics and major surgery, the child recovered well with few sequelae at 14 months of age.

The remaining two septic arthritis cases occurred following arthroplasty and both required replacement of prostheses.26,27 The first of these involved a shoulder prosthesis that was inserted secondary to trauma and was reported as part of a larger series looking at removal of infected prostheses.26 The infection was chronic in nature, requiring three months of antibiotic therapy. The more recent case occurred following primary hip arthroplasty.27 The patient presented approximately three weeks following surgery with elevated inflammatory markers and clinical manifestations of sepsis. As in our case, he was treated successfully with ertapenem, along with an exchange of the prosthetic head and liner.

The remaining nine MSK cases consisted of osteomyelitis, predominantly in the foot12,21,22,28 and vertebral column.2325 Perhaps not surprisingly, the organism favours the extremes of age and ‘at risk’ or immunocompromised groups,16,2123 with diabetes mellitus and peripheral vascular disease posing a significant risk for the development of pedal osteomyelitis.

In total, five of the previously reported cases of C koseri MSK infections were associated with an operative procedure and three involved an implanted device (Table 1). Other MSK infections involving the organism have been reported as part of larger cohorts with little individual case detail.4,29 The organism can be difficult to detect, which means that samples taken for microbiological analysis frequently take prolonged periods of time to be reported positive and it may appear in combination with a variety of other organisms.12,21,22,27 C koseri bacteraemia may itself predispose to other, polymicrobial infections,4 adding to its overall risk profile. Antibiotics alone are unlikely to be effective; resistance to penicillins is common4,29 and there are some reports of resistance to newer antibiotics.24

Conclusions

C koseri poses a significant risk following orthopaedic procedures, in particular arthroplasty surgery, with two of the most recently reported joint infections occurring following such procedures. There can be a delay in diagnosis and multiple samples may be required before the organism is identified microbiologically. Despite the aggressive nature of C koseri MSK infections, with rapid diagnosis the organism responds well to newer beta-lactam and cephalosporin-based antibiotics as well as timely surgery. Health workers involved in the care of orthopaedic patients with suspected surgical site infections should be vigilant for C koseri as a potential causative organism.

References

  • 1.Salzler MJ, Lin A, Miller CD et al. Complications after arthroscopic knee surgery. Am J Sports Med 2014; : 292–296. [DOI] [PubMed] [Google Scholar]
  • 2.Bauer T, Boisrenoult P, Jenny JY. Post-arthroscopy septic arthritis: current data and practical recommendations. Orthop Traumatol Surg Res 2015; : S347–S350. [DOI] [PubMed] [Google Scholar]
  • 3.Lin SY, Ho MW, Yang YF et al. Abscess caused by Citrobacter koseri infection: three case reports and a literature review. Intern Med 2011; : 1,333–1,337. [DOI] [PubMed] [Google Scholar]
  • 4.Drelichman V, Band JD. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med 1985; : 1,808–1,810. [PubMed] [Google Scholar]
  • 5.Doran TI. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis 1999; : 384–394. [DOI] [PubMed] [Google Scholar]
  • 6.Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev 2002; : 527–544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Kaandorp CJ, Krijnen P, Moens HJ et al. The outcome of bacterial arthritis. Arthritis Rheum 1997; : 884–892. [DOI] [PubMed] [Google Scholar]
  • 8.García-De La Torre I. Advances in the management of septic arthritis. Infect Dis Clin North Am 2006; : 773–788. [DOI] [PubMed] [Google Scholar]
  • 9.Sharff KA, Richards EP, Townes JM. Clinical management of septic arthritis. Curr Rheumatol Rep 2013; : 332. [DOI] [PubMed] [Google Scholar]
  • 10.Deirmengian C, Kardos K, Kilmartin P et al. The alpha-defensin test for periprosthetic joint infection outperforms the leukocyte esterase test strip. Clin Orthop Relat Res 2015; : 198–203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Drinka PJ, Gauerke C, Miller J et al. Apparent transmission of Citrobacter koseri in catheterized residents on a 17-bed nursing home wing. J Am Geriatr Soc 2003; : 140–141. [DOI] [PubMed] [Google Scholar]
  • 12.Lipsky BA, Hook EW, Smith AA, Plorde JJ. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis 1980; : 746–760. [DOI] [PubMed] [Google Scholar]
  • 13.Del Pozo JL, Patel R. Clinical practice. Infection associated with prosthetic joints. N Engl J Med 2009; : 787–794. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Vaz Marecos C, Ferreira M, Ferreira MM, Barroso MR. Sepsis, meningitis and cerebral abscesses caused by Citrobacter koseri. BMJ Case Rep 2012; bcr1020114941. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Jansen RD, Meadow WL, Schwartz IK, Ogata ES. ‘Bacteriological bit’: Citrobacter diversus osteomyelitis in a neonate. Clin Pediatr 1981; : 791. [PubMed] [Google Scholar]
  • 16.Hayani KC. Citrobacter koseri osteomyelitis in an infant. Acta Paediatr Jpn 1997; : 390–391. [DOI] [PubMed] [Google Scholar]
  • 17.Straussberg R, Harel L, Amir J. Long-term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage. Infection 2001; : 280–282. [DOI] [PubMed] [Google Scholar]
  • 18.McPherson C, Gal P, Ransom JL. Treatment of Citrobacter koseri infection with ciprofloxacin and cefotaxime in a preterm infant. Ann Pharmacother 2008; : 1,134–1,138. [DOI] [PubMed] [Google Scholar]
  • 19.Holt RJ, Gorrochategui M, Perez C. Hypoprothrombinemia associated with moxalactam treatment of a septic sternoclavicular arthritis due to Citrobacter diversus. Drug Intell Clin Pharm 1981; : 288–289. [DOI] [PubMed] [Google Scholar]
  • 20.Fuxench-Chiesa Z, Mejias E, Ramirez-Ronda CH. Septic arthritis of the sternoclavicular joint due to Citrobacter diversus. J Rheumatol 1983; : 162–164. [PubMed] [Google Scholar]
  • 21.Boberg JS, Yu GV, Cavaliere RG, Ruch JA. Citrobacter diversus osteomyelitis. A case report. J Am Podiatry Assoc 1984; : 300–304. [DOI] [PubMed] [Google Scholar]
  • 22.Simons WJ, Lee TJ. Aztreonam in the treatment of bone and joint infections caused by gram-negative bacilli. Rev Infect Dis 1985; : S783–S788. [DOI] [PubMed] [Google Scholar]
  • 23.Müllner GF, Keller H. Spondylitis due to Citrobacter diversus. Case report and review of Citrobacter diversus infections. Schweiz Med Wochenschr 1992; : 1,173–1,177. [PubMed] [Google Scholar]
  • 24.Sotto A, Bernard JC, Brunschwig C et al. Bifocal cervical spondylodiscitis due to Citrobacter diversus. Infection 1994; : 423–424. [DOI] [PubMed] [Google Scholar]
  • 25.Canario DG, Remé P, Cunha BA. Citrobacter koseri infection and abscess associated with Harrington rods. Am J Infect Control 2004; 372–374. [DOI] [PubMed] [Google Scholar]
  • 26.Maynou C, Ménager S, Senneville E et al. Clinical results of resection arthroplasty for infected shoulder arthroplasty. Rev Chir Orthop Reparatrice Appar Mot 2006; : 567–574. [DOI] [PubMed] [Google Scholar]
  • 27.Kaufman AM, Watters TS, Henderson RA et al. Citrobacter koseri as a cause of early periprosthetic infection after primary total hip arthroplasty. J Arthroplasty 2011; : 978.e13–978.e16. [DOI] [PubMed] [Google Scholar]
  • 28.Yagci S, Arslan K, Tufan ZK et al. Osteomyelitis due to Citrobacter koseri infection in a diabetic patient. J Endocrinol Metab 2011; : 146–148. [Google Scholar]
  • 29.Altmann G, Sechter I, Braunstein I, Gerichter CB. Citrobacter koseri isolated in Israel, 1972–83. Isr J Med Sci 1984; : 1,056–1,060. [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES